SCHEMBL9687229

SCHEMBL9687229

Cc1cccc(NC(=O)c2ccncc2)c1COc1cccnc1[N+](=O)[O-]

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.51
MAPT P10636 3/20 0.46
HTT P42858 3/20 0.46
POLB P06746 3/20 0.46
ALDH1A1 P00352 2/20 0.46
ESR2 Q92731 1/20 0.46
NPC1 O15118 3/20 0.45
RAB9A P51151 2/20 0.45
SGMS2 Q8NHU3 1/20 0.44
MEN1 O00255 3/20 0.43
LMNA P02545 2/20 0.43
GAA P10253 1/20 0.43
THRB P10828 1/20 0.43
KDR P35968 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Pyridine SCHEMBL10560765 0.97 KMT2A (0.48) KMT2AMAPTHTTPOLBALDH1A1
SCHEMBL9687480 0.87 KMT2A (0.55) KMT2AMAPTHTTPOLBALDH1A1
SCHEMBL9686889 0.85 KMT2A (0.51) KMT2AMAPTHTTPOLBALDH1A1
SCHEMBL9686420 0.84 SGMS2 (0.47) KMT2AMAPTPOLBRAB9ASGMS2
SCHEMBL9686263 0.82 KMT2A (0.48) KMT2AMAPTHTTPOLBALDH1A1
SCHEMBL9687530 0.82 KMT2A (0.48) KMT2AMAPTHTTPOLBALDH1A1
SCHEMBL9686346 0.82 KMT2A (0.52) KMT2AMAPTHTTPOLBALDH1A1
SCHEMBL9685684 0.81 NPC1 (0.53) KMT2AMAPTHTTPOLBALDH1A1
SCHEMBL10561858 0.81 KMT2A (0.58) KMT2AMAPTHTTPOLBALDH1A1
SCHEMBL9687429 0.78 KMT2A (0.46) KMT2AMAPTHTTPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0268989-B1 IMIDAZOPYRIDINE COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-07-08 EP disclosed
EP-0268989-A1 Imidazopyridine compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-06-01 EP disclosed